HLTH 2022 had concluded in Las Vegas this week. Among the multitude of announcements we found five interesting reports and studies. Take a look.Read More
Reports Surveys Studies
The College of Healthcare Information Management Executives (CHIME) celebrates revolutionary achievement in digital health for 18 organizations awarded at the highest level of the CHIME Digital Health Most Wired Survey with level 10 certification.
By David Burda – No matter who I’m interviewing, no matter what the topic, and I ask them what the biggest obstacle or barrier to doing X is, their answer invariably is the CFO. That is, unless I’m interviewing the CFO. We need to be able to explain this to the CFO. We need to demonstrate the return on investment to the CFO.
AMA releases newest update to their Digital Health Research survey on physician adoption of digital health and there has been an increase in the percentage of physicians that feel there are advantages in leveraging digital health solutions. Here is what our experts have to say about the findings.
This month’s roundup of surveys and reports from around the industry includes Rx adherence better with electronic prescriptions, leveraging AI in hospitals, Alzheimer’s and multivitamins, hospital margins continue to drop, physician’s seeing digital health benefits, and more RPM in cardiac care since pandemic.
Our recent roundup of surveys and reports from around the industry. We are still talking and studying COVID, its impact and how it will help prepare for future pandemics. We are still seeing supply chain and labor challenges. And will we ever really see cost savings in healthcare? Check out these studies.
Our recent roundup of surveys and reports from around the industry. This month includes ransomware, trusting medical imaging AI, cost transparency, No Surprises Act, data capacities for patient-centered care, controlled Rx management, and hospital profit margins.
By David Burda – By now, we all know that hospitals’ level of compliance with the new price transparency rule would not be described as robust. It’s whatever the opposite of robust is. Feeble? Pathetic? Weak? There’s been a lot of speculation as to why even at this point, nearly 18 months after the rule went into effect.
By David Burda – By any measure or definition, we’re a long way from full adoption of value-based care reimbursement in the U.S. The questions are why and what can we do about it? All we know as consumers of medical care and journalists who write about these things are what payers and providers tell us about why payments still aren’t based on outcomes.